Research Paper Volume 13, Issue 19 pp 22666—22689

Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study

(A) Log Plasma BDNF levels in all-cause MCI cases compared to controls, with various sensitivity analyses including and removing co-morbidities. * indicates pB) Log Plasma BDNF levels in non-amnestic (non-a) MCI cases compared to controls, with various sensitivity analyses including and removing co-morbidities.* indicates p

Figure 1. (A) Log Plasma BDNF levels in all-cause MCI cases compared to controls, with various sensitivity analyses including and removing co-morbidities. * indicates p<0.05, ***indicates p<0.01, and ***indicates p<0.001. (B) Log Plasma BDNF levels in non-amnestic (non-a) MCI cases compared to controls, with various sensitivity analyses including and removing co-morbidities.* indicates p<0.05, ***indicates p<0.01, and ***indicates p<0.001.